Results 41 to 50 of about 26,977 (247)

Recurrent Ventricular Fibrillation Associated With Graves' Disease: A Case Report

Case Reports in Cardiology
Although tachyarrhythmias are associated with thyrotoxicosis, the association with ventricular fibrillation is unknown. This case reports a recurrent ventricular fibrillation with Graves' disease that was successfully treated with an implantable ...
In Tae Moon, Sihun Kim, Sung Hun Park, You-Jeong Ki, Jung Yeon Chin   +4 more
doaj   +1 more source

Infection and migration incidence of cardiac implantable electrical devices in Japan: Web‐based survey results

Journal of Arrhythmia, 2020
Web‐based survey was conducted for experiences of cardiac implantable electrical device (CIED) infection and migration in Japan. A total of 155 cardiologists’ answer was collected in January, 2018.
Hiroshi Nakajima, Nobuhiro Nishii
doaj   +1 more source

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia

Annals of Cardiac Anaesthesia, 2020
Long-term survival of patients submitted to a Fontan procedure is reduced because of arrhythmias. Late post-Fontan ventricular tachycardia is extremely rare, but it can be fatal. Consequently, the implantation of an implantable cardioverter defibrillator
Nikolaos A Papakonstantinou, Vasileios Patris, Ilias Samiotis, Michalis Koutouzis, Giasemi Koutouzi, Mihalis Argiriou   +5 more
doaj   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Recurrent cardiac arrest and complete atrioventricular block due to idiopathic coronary vasospasm: A case report

Heliyon
Recurrent complete atrioventricular block induced by coronary spasm is rare. We present a case of a 47-year-old woman who suffered from two episodes of out-of-hospital cardiac arrest within one year due to complete atrioventricular block caused by ...
Wei Gao, Yingwu Liu, Tong Li
doaj   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Simultaneous leadless pacemaker and subcutaneous implantable cardioverter‐defibrillator implantation—When vascular options have run out

Journal of Arrhythmia, 2019
An end‐stage renal failure patient who was planned for a left brachioaxillary arteriovenous graft required an implantable cardioverter‐defibrillator for secondary prevention of ventricular tachycardia and a pacemaker for complete heart block but was ...
Jit Beng Ng, Kelvin Chua, Wee Siong Teo
doaj   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Cost-utility analysis of an implantable cardioverterdefibrillator for the treatment of patients with ischemic or non-ischemic New York Heart Association class II or III heart failure in Colombia

Biomédica: revista del Instituto Nacional de Salud, 2019
Introduction: The use of an implantable cardioverter-defibrillator reduces the probability of sudden cardiac death in patients with heart failure. Objective: To determine the cost-utility relationship of an implantable cardioverter-defibrillator compared
Sara Atehortúa, Juan Manuel Senior, Paula Castro, Mateo Ceballos, Clara Saldarriaga, Nelson Giraldo, Guillermo Mora   +6 more
doaj   +1 more source

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

ESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler, Malcolm Brown, Philippe Prokocimer, Ashley C. Humphries, Sophie Pope, Olivia Wright, Jun Su, Osama Elnawasany, Bogdan Muresan   +8 more
wiley   +1 more source